RP Management, LLC
New York, NY · CIK 1507673 · 13F filing filed 2025-08-06
SEC-registered investment adviser since 2012 · limited liability company
- Assets managed$2.1bn
- Staff2 · 1 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds1 (1 hedge) · $1.2bn gross assets
- Form ADV · 2026-03-31SEC adviser record
- Kindhedge funds
- Others nearbyNew York, NY
As an employer
- Offices in1 country
- Private fundshedge 1
US visa salary filings
- Filings FY20241
- Median salary offered$168,000
- Middle half$168,000 – $168,000
- Job titles1
| Job title | Filings | Median |
|---|---|---|
| Associate, Research And InvestmentsNew York, NY | 1 | $168,000 |
Source: US Department of Labor, Labor Condition Application disclosure data (certified, full-time, yearly equivalent). These are the salaries the employer committed to pay the visa roles it filed for, at least the prevailing wage for the job and place; they are not the pay of all its staff. Filed by: RP Management, LLC.
$0
reported value
-100.0% vs Q1 2025
1positions
—in top 10
1 new
0 added
0 reduced
4 sold out
vs Q1 2025
This report includes the holdings of 1 other manager that shares the investment decisions:
- Legorreta Pablo G. – reports through this filing
Shares in two reports are counted once in each security's totals.
Holdings, Q2 2025
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| N/A 0 | $0— | New |
Sold out since Q1 2025
| Security | Value then |
|---|---|
| BIOHAVEN LTD BHVN | $70.6m2.9m shares |
| CYTOKINETICS INC CYTK | $39.4m980.4k shares |
| BIOCRYST PHARMACEUTICALS INC BCRX | $28.8m3.8m shares |
| VIRACTA THERAPEUTICS INC SNSS | $743.7k shares |